eCysticFibrosis Review
eCysticFibrosis Review
Publishing Details
Contact & Outreach
About This Podcast
Hosted on Acast. See acast.com/privacy for more information.
Explore Statistics
Recent Episodes
Cystic Fibrosis Life Transitions
Until the advent of highly effective CFTR modulator medications, cystic fibrosis was considered a pediatric disease, because most individuals did not survive into adulthood. Now, with more adults…
S7E8 CF and Diet and Nutrition: The Changing Paradigm
Individuals with cystic fibrosis — adults as well infants and children — have long struggled to gain and maintain their weight. But how has the current widespread use of highly effective modulator…
S10E6 ETI (CFTR Triple Therapy): Clinical Opportunities
The advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a number of clinical questions. Are three agents really better than two? For which patients, in what…
S10E4 Pulmonary Exacerbations and IV Antibiotics
Managing pulmonary exacerbations in people with cystic fibrosis: is there high-grade evidence to support best practices? How helpful is the most current guidance? Does the recent research challenge…
S10E2 Race, Ethnicity, and Cystic Fibrosis
Race and ethnicity. How do they affect a patient’s ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determinants of health limit access to appropriate CF…
S9E13 The Pancreas, Malnutrition, and CFTR Modulators
Pancreatic insufficiency. In children with CF, it’s been associated with delayed development and increased odds of developing severe lung disease. How can it be more accurately diagnosed? And what…
CF and COVID-19: The Data and the Real World
Do cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the…
Managing Psychosocial and Economic Stress
Do cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the…
Overcoming Shutdown Challenges
Do cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the…
Maintaining CF Infection Prevention and Control
Do cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the…
S9E11 Clinical Considerations for Women with CF
Studies have shown that adolescent and young adult women with cystic fibrosis often turn to their CF care team for answers to their questions about their sexual and reproductive health. But how…
S9E9 Antibiotics, Dosing, and CFTR
Airway infections are a hallmark of cystic fibrosis, making antibiotic therapies a mainstay of CF treatment. While the fight against ABX resistance is ongoing, newer data are showing that commonly…
S9E7 Bringing Telemedicine to the CF Clinic: A Success Story
No-contact telemedicine to better protect CF clinic patients and staff during this pandemic may sound like a great idea, but is it even possible to institute? In this eCysticFibrosis Review Special…
S9E6 CFTR, Growth & Liver Disease: A Clinical Perspective
Where, beyond the lungs, do CFTR modulators provide beneficial effects? Can treatment promote growth in height and BMI? What’s known about CFTR modulator effects on cystic fibrosis-associated liver…
S9E4 In the Clinic: Triple Combination CFTR Modulation
Elexacaftor/tezacaftor/ivacaftor — the newly approved triple combination CFTR modulator therapy. What are the benefits? For which patients? What are the potential adverse effects? Who’s most…
S9E2 Addressing Mental Health in CF
Anxiety and depression in cystic fibrosis — who do these conditions affect? How much do they influence patient health? How can clinicians identify and manage them? What evidence-based interventions…
S8E13 Clinical Considerations: New Anti-Inflammatories & New CFTR Modulators
New CFTR modulators for F508del mutations? New research into reducing inflammation in the CF lung? In this issue, Dr. Jennifer Taylor-Cousar from National Jewish Health in Denver explains the…
S8E11 Continuous Alternating Therapies: A Clinical Perspective
Inhaled antibiotics have become the foundation of treating chronic respiratory tract Pseudomonas infection in individuals with cystic fibrosis. But what happens when inhaled monotherapy doesn’t…
S8E9 In The Clinic: CFTR Modification & Nutritional Deficiencies
The effects of CFTR modifiers on improving lung function in people with cystic fibrosis are well known. But what about their effects on the GI tract that directly affect nutrition?In this issue, Dr.…
NTM Infection: Today's Treatments & New Antibiotics in Development
Volume 8, Issue 7. Part 3 Hosted on Acast. See acast.com/privacy for more information.
Frequently Asked Questions
eCysticFibrosis Review has published 73 episodes since September 2008, covering topics in Education, Health & Fitness.
eCysticFibrosis Review is currently declining with new episodes every 2 months. Average episode length is 24m.
Sign up on Grep.FM to access contact details for eCysticFibrosis Review, including email and social media links.
Similar Podcasts
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
500 episodes
The Kevin Miller Podcast
Kevin Miller | YAP Media
1,683 episodes
Behind The Knife: The Surgery Podcast
Behind The Knife: The Surgery Podcast
500 episodes
The Premed Years
Ryan Gray
640 episodes
Straight A Nursing: Study for nursing school exams & NCLEX
Maureen Osuna, MSN, RN - Nursing school educator, author, and nursing student enthusiast.
545 episodes
Core IM | Internal Medicine Podcast
Core IM Team
217 episodes